{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T05:36:11Z","timestamp":1777527371181,"version":"3.51.4"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,9,26]],"date-time":"2019-09-26T00:00:00Z","timestamp":1569456000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,9,26]],"date-time":"2019-09-26T00:00:00Z","timestamp":1569456000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["BJ-2011-058"],"award-info":[{"award-number":["BJ-2011-058"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis is a severe and most common autoimmune encephalitis in patients under 40\u2009years old. Anti-NMDAR encephalitis has various clinical and neuroimaging findings. Here we report a special case of an anti-NMDAR encephalitis who had diffuse lesions in bilateral hemispheres with mild mass effects in left basal ganglia area.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentations<\/jats:title>\n                    <jats:p>A 28-year-old female anti-NMDAR encephalitis patient mainly presented with headache and fever. Brain magnetic resonance image (MRI) showed slightly contrasted diffuse lesions, involving the left temporal and frontal lobes, left basal ganglia area and splenium of corpus callosum, as well as the right frontal lobe, with mild edema surrounded in the left basal ganglia area. Cerebrospinal fluid (CSF) revealed a moderate pleocytosis with normal protein and glucose levels. Anti-NMDAR antibodies were identified in CSF. Transvaginal ovarian ultrasound did not reveal an ovarian teratoma. The patient was treated with immunoglobulin and steroid, and had a good recovery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Anti-NMDAR encephalitis has no special clinical manifestations and brain MRI is highly variable, which could be unremarkable or abnormal involving white and grey matters. The extensive lesions in frontal and temporal lobes, and basal ganglia area, with mild mass effects, have not been described previously. Recognition of various changes in brain MRI will enable the early detection of anti-NMDAR antibody and then effective treatments.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12883-019-1456-6","type":"journal-article","created":{"date-parts":[[2019,10,25]],"date-time":"2019-10-25T10:56:47Z","timestamp":1572001007000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The diffuse involvement of anti-N-methyl-D-aspartate receptor encephalitis in brain: a case report"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4317-1515","authenticated-orcid":false,"given":"Yun","family":"Jiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianpeng","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Gong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongjun","family":"Hao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haibo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,9,26]]},"reference":[{"key":"1456_CR1","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/ana.21050","volume":"61","author":"J Dalmau","year":"2007","unstructured":"Dalmau J, Tuzun E, Wu HY, Masjuan J, Rossi JE, Voloschin A, Baehring JM, Shimazaki H, Koide R, King D, Mason W, Sansing LH, Dichter MA, Rosenfeld MR, Lynch DR. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol. 2007;61:25\u201336. \n                    https:\/\/doi.org\/10.1002\/ana.21050\n                    \n                  .","journal-title":"Ann Neurol"},{"key":"1456_CR2","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S1474-4422(10)70253-2","volume":"10","author":"J Dalmau","year":"2011","unstructured":"Dalmau J, Lancaster E, Martinez-Hernandez E, Rosenfeld MR, Balice-Gordon R. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol. 2011;10:63\u201374. \n                    https:\/\/doi.org\/10.1016\/S1474-4422(10)70253-2\n                    \n                  .","journal-title":"Lancet Neurol"},{"key":"1456_CR3","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/6361479","volume":"2017","author":"CY Liu","year":"2017","unstructured":"Liu CY, Zhu J, Zheng XY, Ma C, Wang X. Anti-N-methyl-D-aspartate receptor encephalitis: a severe, potentially reversible autoimmune encephalitis. Mediat Inflamm. 2017;2017:6361479. \n                    https:\/\/doi.org\/10.1155\/2017\/6361479\n                    \n                  .","journal-title":"Mediat Inflamm"},{"key":"1456_CR4","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/S1474-4422(08)70224-2","volume":"7","author":"J Dalmau","year":"2008","unstructured":"Dalmau J, Gleichman AJ, Hughes EG, Rossi JE, Peng X, Lai M, Dessain SK, Rosenfeld MR, Balice-Gordon R, Lynch DR. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol. 2008;7:1091\u20138. \n                    https:\/\/doi.org\/10.1016\/S1474-4422(08)70224-2\n                    \n                  .","journal-title":"Lancet Neurol"},{"key":"1456_CR5","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1212\/WNL.0b013e3182a4a49c","volume":"81","author":"MJ Titulaer","year":"2013","unstructured":"Titulaer MJ, McCracken L, Gabilondo I, Iizuka T, Kawachi I, Bataller L, Torrents A, Rosenfeld MR, Balice-Gordon R, Graus F, Dalmau J. Late-onset anti-NMDA receptor encephalitis. Neurology. 2013;81:1058\u201363. \n                    https:\/\/doi.org\/10.1212\/WNL.0b013e3182a4a49c\n                    \n                  .","journal-title":"Neurology"},{"key":"1456_CR6","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/s15010-016-0959-y","volume":"45","author":"F Schein","year":"2017","unstructured":"Schein F, Gagneux-Brunon A, Antoine JC, Lavernhe S, Pillet S, Paul S, Fresard A, Boutet C, Grange R, Cazorla C, Lucht F, Botelho-Nevers E. Anti-N-methyl-D-aspartate receptor encephalitis after herpes simplex virus-associated encephalitis: an emerging disease with diagnosis and therapeutic challenges. Infection. 2017;45:545\u20139. \n                    https:\/\/doi.org\/10.1007\/s15010-016-0959-y\n                    \n                  .","journal-title":"Infection"},{"key":"1456_CR7","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.pediatrneurol.2017.03.010","volume":"72","author":"A Goenka","year":"2017","unstructured":"Goenka A, Jain V, Nariai H, Spiro A, Steinschneider M. Extended clinical Spectrum of anti-N-methyl-d-aspartate receptor encephalitis in children: a case series. Pediatr Neurol. 2017;72:51\u20135. \n                    https:\/\/doi.org\/10.1016\/j.pediatrneurol.2017.03.010\n                    \n                  .","journal-title":"Pediatr Neurol"},{"key":"1456_CR8","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s12883-015-0366-5","volume":"15","author":"RJ Wang","year":"2015","unstructured":"Wang RJ, Chen BD, Qi D. Anti-N-methyl-D-aspartate receptor encephalitis concomitant with multifocal subcortical white matter lesions on magnetic resonance imaging: a case report and review of the literature. BMC Neurol. 2015;15:107. \n                    https:\/\/doi.org\/10.1186\/s12883-015-0366-5\n                    \n                  .","journal-title":"BMC Neurol"},{"key":"1456_CR9","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.nic.2012.12.009","volume":"23","author":"KC Jones","year":"2013","unstructured":"Jones KC, Benseler SM, Moharir M. Anti-NMDA Receptor Encephalitis. Neuroimaging Clin N Am. 2013;23:309\u201320. \n                    https:\/\/doi.org\/10.1016\/j.nic.2012.12.009\n                    \n                  .","journal-title":"Neuroimaging Clin N Am"},{"key":"1456_CR10","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1136\/jnnp-2017-316822","volume":"89","author":"OR Phillips","year":"2018","unstructured":"Phillips OR, Joshi SH, Narr KL, Shattuck DW, Singh M, Di PM, Ploner CJ, Pruss H, Paul F, Finke C. Superficial white matter damage in anti-NMDA receptor encephalitis. J Neurol Neurosurg Psychiatry. 2018;89:518\u201325. \n                    https:\/\/doi.org\/10.1136\/jnnp-2017-316822\n                    \n                  .","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1456_CR11","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S1474-4422(12)70310-1","volume":"12","author":"MJ Titulaer","year":"2013","unstructured":"Titulaer MJ, McCracken L, Gabilondo I, Armangue T, Glaser C, Iizuka T, Honig LS, Benseler SM, Kawachi I, Martinez-Hernandez E, Aguilar E, Gresa-Arribas N, Ryan-Florance N, Torrents A, Saiz A, Rosenfeld MR, Balice-Gordon R, Graus F, Dalmau J. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol. 2013;12:157\u201365. \n                    https:\/\/doi.org\/10.1016\/S1474-4422(12)70310-1\n                    \n                  .","journal-title":"Lancet Neurol"},{"key":"1456_CR12","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1212\/WNL.0000000000005517","volume":"90","author":"S Chiang","year":"2018","unstructured":"Chiang S, Garg T, Hu A, Amin H, Davalos-Balderas A, Alfradique-Dunham I, Goldsmith CE. Pearls & oy-sters: relapse of anti-NMDA receptor encephalitis after prior first- and second-line immunotherapy. Neurology. 2018;90:936\u20139. \n                    https:\/\/doi.org\/10.1212\/WNL.0000000000005517\n                    \n                  .","journal-title":"Neurology"},{"key":"1456_CR13","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s10072-015-2385-9","volume":"37","author":"T Lu","year":"2016","unstructured":"Lu T, Cai W, Qiu W, Sun X, Lu Z. Brainstem and vestibulocochlear nerve involvement in relapsing-remitting anti-NMDAR encephalitis. Neurol Sci. 2016;37:149\u201351. \n                    https:\/\/doi.org\/10.1007\/s10072-015-2385-9\n                    \n                  .","journal-title":"Neurol Sci"},{"key":"1456_CR14","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1136\/jnnp-2011-301969","volume":"83","author":"F Leypoldt","year":"2012","unstructured":"Leypoldt F, Buchert R, Kleiter I, Marienhagen J, Gelderblom M, Magnus T, Dalmau J, Gerloff C, Lewerenz J. Fluorodeoxyglucose positron emission tomography in anti-N-methyl-D-aspartate receptor encephalitis: distinct pattern of disease. J Neurol Neurosurg Psychiatry. 2012;83:681\u20136. \n                    https:\/\/doi.org\/10.1136\/jnnp-2011-301969\n                    \n                  .","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1456_CR15","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.jneuroim.2016.05.016","volume":"297","author":"J Novy","year":"2016","unstructured":"Novy J, Allenbach G, Bien CG, Guedj E, Prior JO, Rossetti AO. FDG-PET hyperactivity pattern in anti-NMDAr encephalitis. J Neuroimmunol. 2016;297:156\u20138. \n                    https:\/\/doi.org\/10.1016\/j.jneuroim.2016.05.016\n                    \n                  .","journal-title":"J Neuroimmunol"},{"key":"1456_CR16","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S1474-4422(13)70282-5","volume":"13","author":"N Gresa-Arribas","year":"2014","unstructured":"Gresa-Arribas N, Titulaer MJ, Torrents A, Aguilar E, McCracken L, Leypoldt F, Gleichman AJ, Balice-Gordon R, Rosenfeld MR, Lynch D, Graus F, Dalmau J. Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study. Lancet Neurol. 2014;13:167\u201377. \n                    https:\/\/doi.org\/10.1016\/S1474-4422(13)70282-5\n                    \n                  .","journal-title":"Lancet Neurol"},{"key":"1456_CR17","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1212\/WNL.0b013e3182698cd8","volume":"79","author":"SE Schmitt","year":"2012","unstructured":"Schmitt SE, Pargeon K, Frechette ES, Hirsch LJ, Dalmau J, Friedman D. Extreme delta brush: a unique EEG pattern in adults with anti-NMDA receptor encephalitis. Neurology. 2012;79:1094\u2013100. \n                    https:\/\/doi.org\/10.1212\/WNL.0b013e3182698cd8\n                    \n                  .","journal-title":"Neurology"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-019-1456-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12883-019-1456-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-019-1456-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,24]],"date-time":"2020-09-24T19:07:38Z","timestamp":1600974458000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-019-1456-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,26]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1456"],"URL":"https:\/\/doi.org\/10.1186\/s12883-019-1456-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.2.1815\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.1815\/v2","asserted-by":"object"}]},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,26]]},"assertion":[{"value":"10 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"As this is a case report describing clinical observations, ethic approval was waived.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The patient agreed and provided written informed consent for publication of this case report.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declared that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"230"}}